Figure 1
Figure 1. Probability of 10-year overall survival in sickle cell disease (SCD) patients who received hydroxyurea and in SCD patients who were conventionally treated: 86% versus 65% (P = .001).

Probability of 10-year overall survival in sickle cell disease (SCD) patients who received hydroxyurea and in SCD patients who were conventionally treated: 86% versus 65% (P = .001).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal